Vivopharm Holding ApS: Financial statements 2023
CVR: 41452935
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Vivopharm Holding ApS (CVR 41452935) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -6,863 and a net result of DKK -7,473 compared with DKK -107,181 the year before. Equity in the 2023 report amounted to DKK -27,154. The company had 1 employee in the financial year.
- Gross Profit
- DKK -6,863
- Profit/Loss
- DKK -7,473
- Equity
- DKK -27,154
- Total Assets
- DKK 0
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -7K | -7K | -27K | 1 |
| 2022 | - | -7K | -107K | -20K | 1 |
| 2021 | - | -6K | -6K | 88K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Vivopharm Holding ApS has published its annual report for 2022. Gross profit came to DKK -7,181, and the net result was DKK -107,181.
About Vivopharm Holding ApS
Vivopharm Holding ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Gert Mads Bolwig. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,131 and a net result of DKK -8,935 compared with DKK -8,097 the year before. Equity in the 2025 report amounted to DKK -44,186.